Clinical trial • Phase I • Neurology
Clinical trial in Alzheimer's disease | Healthy volunteers
Phase I trial for Alzheimer's disease | Healthy volunteers. 40 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Alzheimer's disease | Healthy volunteers
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 26-11-2024
- First CTIS Authorization Date
- 10-01-2025
Trial design
Phase I trial across 1 site in Austria.
- Target Sample Size
- 40
Eligibility
Recruits 40 No vulnerable population selected (isVulnerablePopulationSelected = false). Trial population comprises healthy volunteers and Alzheimer’s disease patients; no specific consent/assent details provided in the record..
- Vulnerable Population
- No vulnerable population selected (isVulnerablePopulationSelected = false). Trial population comprises healthy volunteers and Alzheimer’s disease patients; no specific consent/assent details provided in the record.
Recruitment
- Planned Sample Size
- 40
- Recruitment Window Months
- 94
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 40
Austria
- Earliest CTIS Part Ii Submission Date
- 06-12-2024
- Latest Decision Or Authorization Date
- 17-01-2025
- Processing Time Days
- 42
- Number Of Sites
- 1
- Number Of Participants
- 40
Sites
- Site Name
- Medical University Of Vienna
- Department Name
- Department of Clinical Pharmacology
- Contact Person Name
- Markus Zeitlinger
- Contact Person Email
- markus.zeitlinger@meduniwien.ac.at
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.
- OCRELIZUMAB for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Secondary progressive multiple sclerosis (active)
- CENOBAMATE for Partial-onset (focal) seizures
- Ocrelizumab for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Active secondary progressive multiple sclerosis
- Clinical trial in Parkinson's disease
- Tenecteplase for Acute ischaemic stroke due to basilar artery occlusion | Posterior circulation ischaemic stroke